Mycoplasma Testing Market: By Product, By Technology, By Application By End-Use and Region Forecast 2020-2031

download arrow download arrow Download Sample
settings arrow settings arrow email us

Mycoplasma Testing Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product (Kits & Reagents, Instruments), By Technology (PCR, ELISA, Direct Assay, Indirect Assay, Enzymatic Methods, DNA Staining, Others), By Application (Cell Line Testing, Virus Testing, Others) By End-Use (Academic Research Institutes, Cell Banks, Pharmaceutical & Biotechnology Companies, Others) and Region Forecast 2020-2031

checked icon checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Mycoplasma Testing Market size was valued at US$ 1,068.9 million in 2024 and is expected to reach US$ 2,606.5 million by 2031, growing at a significant CAGR of 13.6% from 2025-2031. Mycoplasma testing is a medical procedure done by medical professionals to help quickly detect or rule out mycoplasma contamination of cell cultures. This approach consists of tests that either assess antibodies in the blood generated in response to a mycoplasma infection or directly detect the organism by culture or detection of its genetic material (DNA) in a bodily sample.The kits & reagents segment is anticipated to grow at a significant CAGR over the forecast years owing to the increased usage of kit-based procedures for mycoplasma testing, as well as the frequent procurement of these consumables as opposed to equipment, which are major factors driving the expansion of this market sector.

Moreover, the market players are focusing on launching new products, acquisitions, and collaboration. For Instance, In May 2022, Lonza, which is one of the leading organizations in the pharmaceuticals and biotech industry, announced the collaboration with Israel Biotech Fund to work in Biologics and Molecular development. Growing concerns over cell culture contamination, Increasing R&D efforts have anticipated in massive income for the market. Moreover, increasing use of breakthrough technology is projected to drive growth even further. Another aspect driving expansion is the rise in cell culture contamination.

Key Developments

  • In April 2022, Charles River Laboratories International announced the acquisition of Explora BioLabs, a vivarium research service provider. It will help the researchers and clients to boost the early-stage research comprehensively.
  • In July 2020, Roche Diagnostics will introduce Cobas 6800, a fully automated system, in India.

summary download arrow Download Sample

Mycoplasma Testing Market Summary

Study Period

2025-2031

Base Year

2024

CAGR

13.6%

Largest Market

North-America

Fastest Growing Market

Asia-Pacific

Mycoplasma Testing Market Dynamics

The growing need for mycoplasma testing, rising markets, and increased pharmaceutical outsourcing are the major drivers driving the growth of the market during the projected period. Furthermore, increased research and development in life science research and an increase in cell-line contamination contribute to the market's overall growth. Growing concerns about cell culture contamination are also likely to boost market expansion. However, new growing markets stymie market expansion. The market's progress is expected to be slowed down by downward pricing pressure due to its commodity character throughout the projected period.

Mycoplasma Testing Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2025-2031

Market Size in 2024

US$ 1,068.9 million

Market Size in 2031

US$ 2,606.5 million

Market CAGR

13.6%

By Product

  • Kits & Reagents
  • Instruments

By Technology

  • PCR
  • ELISA
  • Direct Assay
  • Indirect Assay
  • Enzymatic Methods
  • DNA Staining
  • Others

By Application

  • Cell Line Testing
  • Virus Testing
  • Others

By End User

  • Academic Research Institutes
  • Cell Banks
  • Pharmaceutical & Biotechnology Companies
  • Others

By Region

  • North America (U.S., Canada)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
  • Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
  • Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

Key Features of the Report

  • The mycoplasma testing market report provides granular level information about the market size, regional market share, historic market (2020-2024), and forecast (2025-2031)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porters Five Force Analysis

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

Mycoplasma testing market size was valued at US$ 1,068.9 million in 2024 and is expected to reach US$ 2,606.5 million by 2031, growing at a significant CAGR of 13.6%.

Thermo Fisher Scientific, Inc. (US), Charles River Laboratories International, Inc. (US), Lonza Group Ltd. (Switzerland), Merck KGaA (Germany), Roche Diagnostics (Switzerland), American Type Culture Collection (US), Bionique Testing Laboratories, Inc. (US), InvivoGen (US), PromoCell GmbH (Germany), Biological Industries Israel Beit Haemek Ltd. (Israel)

asia pacific is the fastest-growing region for the market.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Mycoplasma Testing Market Introduction 
2.1.Global Mycoplasma Testing Market  - Taxonomy
2.2.Global Mycoplasma Testing Market  - Definitions
2.2.1.Product
2.2.2.Technology
2.2.3.Application
2.2.4. End User
2.2.5.Region
3.Global Mycoplasma Testing Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Mycoplasma Testing Market Analysis, 2020-2024 and Forecast 2025-2031
4.1.  Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Mycoplasma Testing Market  By Product, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million)
5.1. Kits & Reagents
5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Instruments
5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
6.Global Mycoplasma Testing Market  By Technology, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million)
6.1. PCR
6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. ELISA
6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Direct Assay
6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Indirect Assay
6.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Enzymatic Methods
6.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. DNA Staining
6.6.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.6.3. Market Opportunity Analysis 
6.7. Others
6.7.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.7.3. Market Opportunity Analysis 
7.Global Mycoplasma Testing Market  By Application, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million)
7.1. Cell Line Testing
7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Virus Testing
7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Others
7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.Global Mycoplasma Testing Market  By  End User, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million)
8.1. Academic Research Institutes
8.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Cell Banks
8.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Pharmaceutical & Biotechnology Companies
8.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Others
8.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
9.Global Mycoplasma Testing Market  By Region, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10.North America Mycoplasma Testing Market ,2020-2024 and Forecast 2025-2031 (Sales Value USD Million)
10.1. Product Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Kits & Reagents
10.1.2.Instruments
10.2.  Technology Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.PCR
10.2.2.ELISA
10.2.3.Direct Assay
10.2.4.Indirect Assay
10.2.5.Enzymatic Methods
10.2.6.DNA Staining
10.2.7.Others
10.3.  Application Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Cell Line Testing
10.3.2.Virus Testing
10.3.3.Others
10.4.   End User Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Academic Research Institutes
10.4.2.Cell Banks
10.4.3.Pharmaceutical & Biotechnology Companies
10.4.4.Others
10.5.  Country Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11.Europe Mycoplasma Testing Market ,2020-2024 and Forecast 2025-2031 (Sales Value USD Million)
11.1. Product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Kits & Reagents
11.1.2.Instruments
11.2.  Technology Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.PCR
11.2.2.ELISA
11.2.3.Direct Assay
11.2.4.Indirect Assay
11.2.5.Enzymatic Methods
11.2.6.DNA Staining
11.2.7.Others
11.3.  Application Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Cell Line Testing
11.3.2.Virus Testing
11.3.3.Others
11.4.   End User Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Academic Research Institutes
11.4.2.Cell Banks
11.4.3.Pharmaceutical & Biotechnology Companies
11.4.4.Others
11.5.  Country Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
11.5.7.
12.Asia Pacific (APAC) Mycoplasma Testing Market ,2020-2024 and Forecast 2025-2031 (Sales Value USD Million)
12.1. Product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Kits & Reagents
12.1.2.Instruments
12.2.  Technology Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.PCR
12.2.2.ELISA
12.2.3.Direct Assay
12.2.4.Indirect Assay
12.2.5.Enzymatic Methods
12.2.6.DNA Staining
12.2.7.Others
12.3.  Application Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Cell Line Testing
12.3.2.Virus Testing
12.3.3.Others
12.4.   End User Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Academic Research Institutes
12.4.2.Cell Banks
12.4.3.Pharmaceutical & Biotechnology Companies
12.4.4.Others
12.5.  Country Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13.Middle East and Africa (MEA) Mycoplasma Testing Market ,2020-2024 and Forecast 2025-2031 (Sales Value USD Million)
13.1. Product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Kits & Reagents
13.1.2.Instruments
13.2.  Technology Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.PCR
13.2.2.ELISA
13.2.3.Direct Assay
13.2.4.Indirect Assay
13.2.5.Enzymatic Methods
13.2.6.DNA Staining
13.2.7.Others
13.3.  Application Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Cell Line Testing
13.3.2.Virus Testing
13.3.3.Others
13.4.   End User Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Academic Research Institutes
13.4.2.Cell Banks
13.4.3.Pharmaceutical & Biotechnology Companies
13.4.4.Others
13.5.  Country Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14.Latin America Mycoplasma Testing Market ,2020-2024 and Forecast 2025-2031 (Sales Value USD Million)
14.1. Product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Kits & Reagents
14.1.2.Instruments
14.2.  Technology Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.PCR
14.2.2.ELISA
14.2.3.Direct Assay
14.2.4.Indirect Assay
14.2.5.Enzymatic Methods
14.2.6.DNA Staining
14.2.7.Others
14.3.  Application Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Cell Line Testing
14.3.2.Virus Testing
14.3.3.Others
14.4.   End User Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Academic Research Institutes
14.4.2.Cell Banks
14.4.3.Pharmaceutical & Biotechnology Companies
14.4.4.Others
14.5.  Country Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Thermo Fisher Scientific, Inc. (US)
15.2.2.Charles River Laboratories International, Inc. (US)
15.2.3.Lonza Group Ltd. (Switzerland),
15.2.4.Merck KGaA (Germany),
15.2.5.Roche Diagnostics (Switzerland)
15.2.6.American Type Culture Collection (US)
15.2.7.Bionique Testing Laboratories, Inc. (US)
15.2.8.InvivoGen (US)
15.2.9.PromoCell GmbH (Germany)
15.2.10.Biological Industries Israel Beit Haemek Ltd. (Israel)
16. Research Methodology 
17. Appendix and Abbreviations 

Key Market Players

  • Thermo Fisher Scientific, Inc. (US)
  • Charles River Laboratories International, Inc. (US)
  • Lonza Group Ltd. (Switzerland),
  • Merck KGaA (Germany),
  • Roche Diagnostics (Switzerland)
  • American Type Culture Collection (US)
  • Bionique Testing Laboratories, Inc. (US)
  • InvivoGen (US)
  • PromoCell GmbH (Germany)
  • Biological Industries Israel Beit Haemek Ltd. (Israel)

Related Industry Reports

Immunoassay Market

Global Blood Grouping Reagents Market